175 related articles for article (PubMed ID: 26170678)
1. Managing infertility with the follitropin alfa prefilled pen injector - patient considerations.
Bühler K
Ther Clin Risk Manag; 2015; 11():995-1001. PubMed ID: 26170678
[TBL] [Abstract][Full Text] [Related]
2. Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study.
Welcker JT; Nawroth F; Bilger W
Reprod Biol Endocrinol; 2010 Sep; 8():111. PubMed ID: 20843323
[TBL] [Abstract][Full Text] [Related]
3. Patient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory women.
Somkuti SG; Schertz JC; Moore M; Ferrande L; Kelly E;
Curr Med Res Opin; 2006 Oct; 22(10):1981-96. PubMed ID: 17022858
[TBL] [Abstract][Full Text] [Related]
4. A questionnaire-based survey to assess patient satisfaction, ease-of-learning, ease-of-use, injection site pain and overall patient satisfaction of the follitropin-alpha (Gonal-f) filled-by-mass (FbM) prefilled pen compared with other systems of gonadotrophin administration.
Utsunomiya T; Tanaka A; Tatsumi K; Ezcurra D
Reprod Biol Endocrinol; 2012 Nov; 10():93. PubMed ID: 23167906
[TBL] [Abstract][Full Text] [Related]
5. A redesigned follitropin alfa pen injector for infertility: results of a market research study.
Abbotts C; Salgado-Braga C; Audibert-Gros C
Patient Prefer Adherence; 2011; 5():315-31. PubMed ID: 21792303
[TBL] [Abstract][Full Text] [Related]
6. Administration of follitropin alfa and lutropin alfa combined in a single injection: a feasibility assessment.
Agostinetto R
Reprod Biol Endocrinol; 2009 May; 7():48. PubMed ID: 19450267
[TBL] [Abstract][Full Text] [Related]
7. Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment.
Illingworth PJ; Lahoud R; Quinn F; Chidwick K; Wilkinson C; Sacks G
Patient Prefer Adherence; 2014; 8():813-26. PubMed ID: 24940048
[TBL] [Abstract][Full Text] [Related]
8. Patient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pens.
Porter R; Kissel C; Saunders H; Keck C
Curr Med Res Opin; 2008 Mar; 24(3):727-35. PubMed ID: 18230195
[TBL] [Abstract][Full Text] [Related]
9. The Development of Gonadotropins for Clinical Use in the Treatment of Infertility.
Lunenfeld B; Bilger W; Longobardi S; Alam V; D'Hooghe T; Sunkara SK
Front Endocrinol (Lausanne); 2019; 10():429. PubMed ID: 31333582
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of new quality standards of follitropin alfa on ovarian stimulation: meta-analysis of previous studies.
Saz-Parkinson Z; López-Cuadrado T; Bouza C; Amate JM
BioDrugs; 2009; 23(1):37-42. PubMed ID: 19344190
[TBL] [Abstract][Full Text] [Related]
11. Dose accuracy of the follitropin alfa pen injector 2.0, the follitropin alfa:lutropin alfa 2:1 combination pen injector 2.0 and the choriogonadotropin alfa pen injector 1.0 used for fertility treatment.
Cottell E; Michalet D; Lispi M; Araujo TD; Gleixner R; Longobardi S; D'Hooghe T
Expert Opin Drug Deliv; 2024 Feb; 21(2):337-346. PubMed ID: 38299472
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech.
Leão Rde B; Esteves SC
Clinics (Sao Paulo); 2014; 69(4):279-93. PubMed ID: 24714837
[TBL] [Abstract][Full Text] [Related]
13. Usability engineering study in the European Union of a redesigned follitropin alfa pen injector for infertility treatment.
Jeannerot F; Stüdeli T; Gunther-LaVergne L; Hirning D; Schertz J
Expert Opin Drug Deliv; 2016 Sep; 13(9):1221-9. PubMed ID: 27329677
[TBL] [Abstract][Full Text] [Related]
14. Outcome from consecutive assisted reproduction cycles in patients treated with recombinant follitropin alfa filled-by-bioassay and those treated with recombinant follitropin alfa filled-by-mass.
Balasch J; Fábregues F; Peñarrubia J; Creus M; Manau D; Vidal E; Casamitjana R; Vanrell JA
Reprod Biomed Online; 2004 Apr; 8(4):408-13. PubMed ID: 15149563
[TBL] [Abstract][Full Text] [Related]
15. The redesigned follitropin α pen injector for infertility treatment.
Christen M; Schertz JC; Arriagada P; Keitel J; Müller H
Expert Opin Drug Deliv; 2011 Jun; 8(6):833-9. PubMed ID: 21548843
[TBL] [Abstract][Full Text] [Related]
16. Gonadotrophin products: empowering patients to choose the product that meets their needs.
Weiss N
Reprod Biomed Online; 2007 Jul; 15(1):31-7. PubMed ID: 17623531
[TBL] [Abstract][Full Text] [Related]
17. Follicle-stimulating hormone in clinical practice: an update.
Daya S
Treat Endocrinol; 2004; 3(3):161-71. PubMed ID: 16026112
[TBL] [Abstract][Full Text] [Related]
18. Recombinant follitropin alfa/lutropin alfa in fertility treatment.
Gibreel A; Bhattacharya S
Biologics; 2010 Feb; 4():5-17. PubMed ID: 20161981
[TBL] [Abstract][Full Text] [Related]
19. Dose accuracy of the redesigned follitropin alfa pen injector for infertility treatment.
Jeannerot F; Cusin A; Schertz J
Expert Opin Drug Deliv; 2016 Dec; 13(12):1661-1669. PubMed ID: 27636195
[TBL] [Abstract][Full Text] [Related]
20. An observational study of assisted reproductive technology outcomes in new European Union member states: an overview of protocols used for ovarian stimulation.
Vlaisavljević V; Meden-Vrtovec H; Lewandowski P; Radwan M; Langerova A; Vicena M; Války J; Herman M; Usoniene A; Treijs G
Curr Med Res Opin; 2010 Apr; 26(4):819-25. PubMed ID: 20121657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
